Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Portage Biotech Inc Ord (NQ: PRTG ) 4.890 -0.120 (-2.40%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 5, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Portage Biotech Inc Ord “Stocks Under $1 Gaining Momentum: WBUY, KAVL, OMEX, PRTG, RJDG – Driving Innovation, Market Trends, and Growth Potential” September 18, 2024 Via AB Newswire Portage Biotech CEO Interview Explains Why His Company Can Be Poised To Break Higher In 2H 2021 (NASDAQ: PRTG) July 19, 2021 Via AB Newswire Portage Biotech Added to Russell 2000(R) Index June 29, 2021 Westport, Connecticut--(Newsfile Corp. - June 29, 2021) - Portage Biotech Inc., (NASDAQ: PRTG) ("Portage" or the "Company") a clinical-stage immuno-oncology... Via Newsfile Portage Biotech Inc. Announces Pricing of Public Offering of 1,000,000 Ordinary Shares June 24, 2021 Westport, Connecticut--(Newsfile Corp. - June 24, 2021) - Portage Biotech Inc. (NASDAQ: PRTG) ("Portage" or the "Company") a clinical-stage immuno-oncology... Via Newsfile Topics Regulatory Compliance Exposures Legal Regulatory Portage Biotech Inc. Announces Proposed Offering of Ordinary Shares June 23, 2021 Westport, Connecticut--(Newsfile Corp. - June 23, 2021) - Portage Biotech Inc. (NASDAQ: PRTG) ("Portage" or the "Company") a clinical-stage immuno-oncology... Via Newsfile Topics Regulatory Compliance Exposures Legal Regulatory Portage Biotech Highlights Safety and Survival Data from Intensity Therapeutics' IT-01 Study of INT230-6 (PORT-1) at ASCO 2021 Annual Meeting June 02, 2021 - Data from the IT-01 trial demonstrate the safety of INT230-6... Via Newsfile Portage Biotech Announces Voluntary Delisting from the Canadian Securities Exchange April 16, 2021 Westport, Connecticut--(Newsfile Corp. - April 16, 2021) - Portage Biotech Inc., (NASDAQ: PRTG) (CSE: PBT.U) ("Portage" or the "Company") a... Via Newsfile Portage Biotech Highlights First Patient Dosed in PRECIOUS-01 Study of PORT-3 for the Treatment of NY-ESO-1 Positive Solid Tumors April 08, 2021 - Novel platform allows co-targeting of iNKT cells and tumor antigens... Via Newsfile Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
